ReWalk Robotics Announces Centers for Medicare & Medicaid Services Revised Apr. 2024 DMEPOS Fee Schedule; Includes 'a final lump-sum Medicare purchase fee schedule amount for personal exoskeletons with a ceiling-to-floor range from $109,238 to $81,929, and an established rate of $91,032 for each state. '
Portfolio Pulse from Benzinga Newsdesk
ReWalk Robotics has announced that the Centers for Medicare & Medicaid Services have revised the DMEPOS Fee Schedule for April 2024, setting a final lump-sum Medicare purchase fee for personal exoskeletons. The fee range is set from $109,238 to $81,929, with a standardized rate of $91,032 for each state.
April 12, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ReWalk Robotics' announcement of the revised DMEPOS Fee Schedule by CMS for personal exoskeletons could significantly impact its financial outlook and market demand.
The establishment of a Medicare purchase fee for personal exoskeletons directly impacts ReWalk Robotics by potentially increasing its product's marketability and affordability through Medicare coverage. This regulatory change could lead to increased sales and revenue for the company, positively affecting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100